BackgroundCheck.run
Search For

Dai H Wang, 72Goleta, CA

Dai Wang Phones & Addresses

Goleta, CA   

410 Memorial Dr, Cambridge, MA 02139   

Arcadia, CA   

Memphis, TN   

Fridley, MN   

Springfield, MO   

Cleves, OH   

Mentions for Dai H Wang

Resumes & CV records

Resumes

Dai Wang Photo 23

Dai Lin Wang

Dai Wang Photo 24

Harvard Business School Mba Candidate

Position:
MBA Candidate at Harvard Business School
Location:
Boston, Massachusetts
Industry:
Financial Services
Work:
Harvard Business School - Greater Boston Area since 2012
MBA Candidate
Goldman Sachs - Beijing Jul 2010 - May 2012
IBD Analyst
Goldman Sachs - Beijing Jun 2009 - Aug 2009
Summer Analyst
HSBC - Hong Kong Jun 2008 - Aug 2008
Summer Intern
Education:
Harvard Business School 2012 - 2014
Master of Business Administration (MBA)
Stanford University 2007 - 2010
Bachelor of Science (BS), Mathematics
SFLS 2001 - 2007
Skills:
Financial Modeling, Valuation, Economics, Financial Analysis, Equities
Interests:
Wine, Golf, Investing, Soccer
Dai Wang Photo 25

Dai Wang

Publications & IP owners

Us Patents

Respiratory Syncytial Virus Vaccine

US Patent:
2023011, Apr 13, 2023
Filed:
Aug 30, 2022
Appl. No.:
17/823255
Inventors:
- Cambridge MA, US
Kapil Bahl - Medford MA, US
Amy Espeseth - Chalfont PA, US
Dai Wang - Blue Bell PA, US
Andrew J. Bett - Lansdale PA, US
Assignee:
ModernaTX, Inc. - Cambridge MA
International Classification:
A61K 39/12
A61P 31/14
A61K 9/00
A61K 9/51
C07K 16/10
C12N 7/00
Abstract:
The disclosure relates to respiratory syncytial vims (RSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Herpes Simplex Virus Vaccine

US Patent:
2020005, Feb 20, 2020
Filed:
Apr 25, 2018
Appl. No.:
16/608451
Inventors:
- Cambridge MA, US
Shinu John - Somerville MA, US
Andrew J. Bett - Lansdale PA, US
Danilo R. Casimiro - Harleysville PA, US
Dai Wang - Blue Bell PA, US
Lan Zhang - Chalfont PA, US
Assignee:
Modema TX, Inc. - Cambridge MA
International Classification:
A61K 39/245
A61K 9/51
C12N 7/00
Abstract:
The disclosure relates to herpes simplex virus (HSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Respiratory Syncytial Virus Vaccine

US Patent:
2018027, Sep 27, 2018
Filed:
Oct 21, 2016
Appl. No.:
15/767613
Inventors:
- Cambridge MA, US
Kapil Bahl - Medford MA, US
Amy Espeseth - Chalfont PA, US
Dai Wang - Blue Bell PA, US
Andrew J. Bett - Lansdale PA, US
Assignee:
ModernaTX, INC. - Cambridge MA
International Classification:
A61K 39/12
Abstract:
The disclosure relates to respiratory syncytial virus (RSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.